» Articles » PMID: 18568069

Neuroimaging of Schizophrenia: Structural Abnormalities and Pathophysiological Implications

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2008 Jun 24
PMID 18568069
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia, once considered a psychological malady devoid of any organic brain substrate, has been the focus of intense neuroimaging research. Findings reveal mild but generalized tissue loss as well as more selective focal loss. It is unclear whether these abnormalities reflect neurodevelopmental or neurodegenerative processes, or some combination of each; current evidence favors a preponderance of neurodevelopmental abnormalities. The pattern of brain abnormalities is also influenced by environmental and genetic risk factors, as well as by the course (and possibly even treatment) of this illness. These findings are described in this article.

Citing Articles

Porencephaly and Psychosis: A Rare Case of Neurological and Psychiatric Intersection.

Gupta T, Suresh S, Chadha Y, Toshniwal S, Patil R Cureus. 2024; 16(9):e69486.

PMID: 39416588 PMC: 11480457. DOI: 10.7759/cureus.69486.


Neurostructural changes in schizophrenia and treatment-resistance: a narrative review.

Paul T, See J, Vijayakumar V, Njideaka-Kevin T, Loh H, Lee V Psychoradiology. 2024; 4:kkae015.

PMID: 39399446 PMC: 11467815. DOI: 10.1093/psyrad/kkae015.


Estrogen and psychosis - a review and future directions.

Mu E, Gurvich C, Kulkarni J Arch Womens Ment Health. 2024; 27(6):877-885.

PMID: 38221595 PMC: 11579214. DOI: 10.1007/s00737-023-01409-x.


[F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT receptors in humans.

Courault P, Lancelot S, Costes N, Colom M, Le Bars D, Redoute J Eur J Nucl Med Mol Imaging. 2023; 50(6):1651-1664.

PMID: 36656363 PMC: 10119077. DOI: 10.1007/s00259-022-06103-1.


Associations between aerobic fitness, negative symptoms, cognitive deficits and brain structure in schizophrenia-a cross-sectional study.

Maurus I, Roll L, Keeser D, Karali T, Papazov B, Hasan A Schizophrenia (Heidelb). 2022; 8(1):63.

PMID: 35918344 PMC: 9345912. DOI: 10.1038/s41537-022-00269-1.


References
1.
Kulynych J, Luevano L, Jones D, Weinberger D . Cortical abnormality in schizophrenia: an in vivo application of the gyrification index. Biol Psychiatry. 1997; 41(10):995-9. DOI: 10.1016/S0006-3223(96)00292-2. View

2.
Harrigan S, McGorry P, Krstev H . Does treatment delay in first-episode psychosis really matter?. Psychol Med. 2003; 33(1):97-110. DOI: 10.1017/s003329170200675x. View

3.
Frazier J, Giedd J, Hamburger S, Albus K, Kaysen D, Vaituzis A . Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry. 1996; 53(7):617-24. DOI: 10.1001/archpsyc.1996.01830070065010. View

4.
DeLisi L, Sakuma M, Tew W, Kushner M, Hoff A, Grimson R . Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997; 74(3):129-40. DOI: 10.1016/s0925-4927(97)00012-7. View

5.
Cahn W, Hulshoff Pol H, Lems E, van Haren N, Schnack H, van der Linden J . Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry. 2002; 59(11):1002-10. DOI: 10.1001/archpsyc.59.11.1002. View